Literature DB >> 17626915

Diarrhoea associated with antibiotic use.

Lynne V McFarland.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17626915      PMCID： PMC1914493          DOI： 10.1136/bmj.39255.829120.47

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  13 in total

1.  Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease.

Authors:  Lynne V McFarland
Journal:  Am J Gastroenterol       Date:  2006-04       Impact factor: 10.864

Review 2.  Probiotics for the prevention of antibiotic-associated diarrhea and Clostridium difficile diarrhea.

Authors:  Jeffry A Katz
Journal:  J Clin Gastroenterol       Date:  2006-03       Impact factor: 3.062

3.  Mortality attributable to nosocomial Clostridium difficile-associated disease during an epidemic caused by a hypervirulent strain in Quebec.

Authors:  Jacques Pépin; Louis Valiquette; Benoit Cossette
Journal:  CMAJ       Date:  2005-09-22       Impact factor: 8.262

Review 4.  Probiotics in the prevention and treatment of gastrointestinal infections.

Authors:  Elizabeth S Huebner; Christina M Surawicz
Journal:  Gastroenterol Clin North Am       Date:  2006-06       Impact factor: 3.806

5.  The rise of Clostridium difficile: the effect of length of stay, patient age and antibiotic use.

Authors:  F W Shek; B S Stacey; J Rendell; M D Hellier; P J Hanson
Journal:  J Hosp Infect       Date:  2000-07       Impact factor: 3.926

6.  Antagonistic activity of probiotic lactobacilli and bifidobacteria against entero- and uropathogens.

Authors:  P Hütt; J Shchepetova; K Lõivukene; T Kullisaar; M Mikelsaar
Journal:  J Appl Microbiol       Date:  2006-06       Impact factor: 3.772

7.  Clostridium difficile in the intensive care unit: epidemiology, costs, and colonization pressure.

Authors:  Steven J Lawrence; Laura A Puzniak; Brooke N Shadel; Kathleen N Gillespie; Marin H Kollef; Linda M Mundy
Journal:  Infect Control Hosp Epidemiol       Date:  2007-01-26       Impact factor: 3.254

8.  Evaluation of the efficacy of a probiotic containing Lactobacillus, Bifidobacterium, Enterococcus, and Pediococcus strains in promoting broiler performance and modulating cecal microflora composition and metabolic activities.

Authors:  K C Mountzouris; P Tsirtsikos; E Kalamara; S Nitsch; G Schatzmayr; K Fegeros
Journal:  Poult Sci       Date:  2007-02       Impact factor: 3.352

Review 9.  Probiotics for the prevention of pediatric antibiotic-associated diarrhea.

Authors:  B C Johnston; A L Supina; M Ospina; S Vohra
Journal:  Cochrane Database Syst Rev       Date:  2007-04-18

10.  Design of a multispecies probiotic mixture to prevent infectious complications in critically ill patients.

Authors:  Harro M Timmerman; Laetitia E M Niers; Ben U Ridwan; Catherina J M Koning; Linda Mulder; Louis M A Akkermans; Frans M Rombouts; Ger T Rijkers
Journal:  Clin Nutr       Date:  2007-06-04       Impact factor: 7.324
View more
  9 in total

1.  The effect of a multi-strain probiotic on the resistance toward Escherichia coli challenge in a randomized, placebo-controlled, double-blind intervention study.

Authors:  S J M Ten Bruggencate; S A Girard; E G M Floris-Vollenbroek; R Bhardwaj; T A Tompkins
Journal:  Eur J Clin Nutr       Date:  2014-11-05       Impact factor: 4.016

2.  Quality of life in children with vesicoureteral reflux.

Authors:  Darcie A Kiddoo; Faria Ajamian; Ambikaipakan Senthilselvan; Catherine J Morgan; Maury N Pinsk
Journal:  Pediatr Nephrol       Date:  2011-09-30       Impact factor: 3.714

Review 3.  Towards an understanding of the role of Clostridium perfringens toxins in human and animal disease.

Authors:  Francisco A Uzal; John C Freedman; Archana Shrestha; James R Theoret; Jorge Garcia; Milena M Awad; Vicki Adams; Robert J Moore; Julian I Rood; Bruce A McClane
Journal:  Future Microbiol       Date:  2014       Impact factor: 3.165

4.  Antimicrobial-resistant strains of Clostridium difficile from North America.

Authors:  Fred C Tenover; Isabella A Tickler; David H Persing
Journal:  Antimicrob Agents Chemother       Date:  2012-03-12       Impact factor: 5.191

5.  Univariate and multivariate analysis of risk factors for severe Clostridium difficile-associated diarrhoea: importance of co-morbidity and serum C-reactive protein.

Authors:  Christian Hardt; Thomas Berns; Wolfgang Treder; Franz-Ludwig Dumoulin
Journal:  World J Gastroenterol       Date:  2008-07-21       Impact factor: 5.742

Review 6.  Probiotic products in Canada with clinical evidence: what can gastroenterologists recommend?

Authors:  G Reid; K Anukam; T Koyama
Journal:  Can J Gastroenterol       Date:  2008-02       Impact factor: 3.522

7.  Gut Ruminococcaceae levels at baseline correlate with risk of antibiotic-associated diarrhea.

Authors:  Xiaoqiong Gu; Jean X Y Sim; Wei Lin Lee; Liang Cui; Yvonne F Z Chan; Ega Danu Chang; Yii Ean Teh; An-Ni Zhang; Federica Armas; Franciscus Chandra; Hongjie Chen; Shijie Zhao; Zhanyi Lee; Janelle R Thompson; Eng Eong Ooi; Jenny G Low; Eric J Alm; Shirin Kalimuddin
Journal:  iScience       Date:  2021-12-16

Review 8.  Probiotics for the Prevention of Antibiotic-Associated Diarrhea.

Authors:  Kira Kopacz; Sangita Phadtare
Journal:  Healthcare (Basel)       Date:  2022-08-02

9.  Recommendations for the diagnosis and treatment of Clostridioides difficile infection: An official clinical practice guideline of the Spanish Society of Chemotherapy (SEQ), Spanish Society of Internal Medicine (SEMI) and the working group of Postoperative Infection of the Spanish Society of Anesthesia and Reanimation (SEDAR).

Authors:  E Bouza; J M Aguado; L Alcalá; B Almirante; P Alonso-Fernández; M Borges; J Cobo; J Guardiola; J P Horcajada; E Maseda; J Mensa; N Merchante; P Muñoz; J L Pérez Sáenz; M Pujol; E Reigadas; M Salavert; J Barberán
Journal:  Rev Esp Quimioter       Date:  2020-02-20       Impact factor: 1.553
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.